A. P. Mikhalenka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. P. Mikhalenka has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Oksana Cheslavovna Mazur
The Institute of Genetics and Cytology of the Belarusian National Academy of Sciences
5 shared publications Е. П. Михаленко
Институт генетики и цитологии НАН Беларуси
5 shared publications- Alexander V. Kilchevsky
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
3 shared publications - Ivan V. Zhyltsou
Vitebsk State Order of Peoples’ Friendship Medical University
3 shared publications - A. P. Sukhareva
Clinical Maternity Hospital of the Minsk Region; Belarusian State Medical University
2 shared publications - Asya A. Gusina
⁴Republican Scientific and Practical Center “Mother and Child”, Minsk, Republic of Belarus
2 shared publications
Latest Publications
- 13 October 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 525
Sialidosis Type II in Siblings with a Novel NEU1 Variant: Clinical and Molecular Genetic Analysis
- 13 October 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 525
Sialidosis Type II in Siblings with a Novel NEU1 Variant: Clinical and Molecular Genetic Analysis
- 27 May 2026
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Medical series
- Vol. 23 (2)
The role of molecular genetic markers in the development of comorbid diseases in premature infants
The incidence of morbidity in premature infants remains consistently high. The development of diseases such as bronchopulmonary dysplasia, retinopathy of prematurity, and periventricular leukomalacia in premature infants is a significant medical and social problem. The search for new markers of genetic predisposition to comorbid diseases in premature infants will contribute to an understanding of pathogenetic mechanisms and will help determine the risks of pathologу development. The aim of this study was to identify the influence of polymorphisms of antioxidant system genes ( SOD2 , GSTP1 ) and matrix metalloproteinase genes ( MMP2 , MMP9 ) on the formation of comorbid diseases in premature infants. It was found that carriage of the T allele (CT and TT genotypes) of the rs4880 polymorphism of the SOD2 gene is associated with an increased concentration of lactate in the blood ( p = 0.022). This finding may indicate its role in metabolism and response to oxidative stress. At the same time, the influence of genetic polymorphism of antioxidant defense enzymes (SOD2 and GSTP1) on the risk of developing comorbid pathology has not been established. The factors involved in the pathogenesis of comorbid pathology in preterm infants born at 28–31 weeks of gestation are the AA genotype of the rs17576 locus in the MMP9 gene, as well as the combination of the AA genotype of the rs17576 locus in the MMP9 gene with the GG genotype of the rs243866 locus in the MMP2 gene ( p = 0.01 and p = 0.0037, respectively).
- 27 May 2026
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Medical series
- Vol. 23 (2)
The role of molecular genetic markers in the development of comorbid diseases in premature infants
The incidence of morbidity in premature infants remains consistently high. The development of diseases such as bronchopulmonary dysplasia, retinopathy of prematurity, and periventricular leukomalacia in premature infants is a significant medical and social problem. The search for new markers of genetic predisposition to comorbid diseases in premature infants will contribute to an understanding of pathogenetic mechanisms and will help determine the risks of pathologу development. The aim of this study was to identify the influence of polymorphisms of antioxidant system genes ( SOD2 , GSTP1 ) and matrix metalloproteinase genes ( MMP2 , MMP9 ) on the formation of comorbid diseases in premature infants. It was found that carriage of the T allele (CT and TT genotypes) of the rs4880 polymorphism of the SOD2 gene is associated with an increased concentration of lactate in the blood ( p = 0.022). This finding may indicate its role in metabolism and response to oxidative stress. At the same time, the influence of genetic polymorphism of antioxidant defense enzymes (SOD2 and GSTP1) on the risk of developing comorbid pathology has not been established. The factors involved in the pathogenesis of comorbid pathology in preterm infants born at 28–31 weeks of gestation are the AA genotype of the rs17576 locus in the MMP9 gene, as well as the combination of the AA genotype of the rs17576 locus in the MMP9 gene with the GG genotype of the rs243866 locus in the MMP2 gene ( p = 0.01 and p = 0.0037, respectively).
- Open Access
- 28 August 2025
- Published by Publishing House Belorusskaya Nauka in Doklady of the National Academy of Sciences of Belarus
- Vol. 69 (4) , 296-302
The role of intragenic and intergenic combinations of SFTPB and SFTPC gene polymorphisms in the pathogenesis of respiratory distress syndrome and bronchopulmonary dysplasia in preterm newborns
Genetic polymorphisms of surfactant proteins SP-B and SP-C may contribute to the development of respiratory disorders among preterm newborns. The aim of this study was to analyze the contribution of intergenic and intragenic combinations of SFTPB and SFTPC genotypes to the pathogenesis of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) in preterm infants. A total of 567 newborns were genotyped for the polymorphic loci rs2077079 and rs1130866 of the SFTPB gene as well as rs4715, rs1124, and rs2070687 of the SFTPC gene using real-time PCR with TaqMan probes and Sanger sequencing. In preterm girls, the risk of RDS was significantly higher in those carrying the genotype combinations –18CCSFTPB/413CASFTPC and –18CCSFTPB/436-8CGSFTPC (p = 0.044 and p = 0.03, respectively). The 1580СТSFTPB/ 557ААSFTPC combination was associated with severe RDS regardless of sex (p = 0.019). Among girls, RDS severity was linked to –18CASFTPB/557CCSFTPC and 1580CT/–18CA SFTPB combinations ( p = 0.018 and p = 0.033, respectively), while in boys, the 1580TTSFTPB/413CCSFTPC combination was associated with more severe disease (p = 0.03). In preterm infants with a gestational age of 28–34 weeks, the risk of BPD was associated with the 1580СТSFTPB/413ССSFTPC genotype combination ( p = 0.031). Thus, specific intergenic and intragenic combinations of SFTPB and SFTPC gene polymorphisms are significantly associated with the risk and severity of RDS and BPD in preterm newborns.
- 28 August 2025
- Published by Publishing House Belorusskaya Nauka in Doklady of the National Academy of Sciences of Belarus
- Vol. 69 (4) , 296-302
Open AccessThe role of intragenic and intergenic combinations of SFTPB and SFTPC gene polymorphisms in the pathogenesis of respiratory distress syndrome and bronchopulmonary dysplasia in preterm newborns
Genetic polymorphisms of surfactant proteins SP-B and SP-C may contribute to the development of respiratory disorders among preterm newborns. The aim of this study was to analyze the contribution of intergenic and intragenic combinations of SFTPB and SFTPC genotypes to the pathogenesis of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) in preterm infants. A total of 567 newborns were genotyped for the polymorphic loci rs2077079 and rs1130866 of the SFTPB gene as well as rs4715, rs1124, and rs2070687 of the SFTPC gene using real-time PCR with TaqMan probes and Sanger sequencing. In preterm girls, the risk of RDS was significantly higher in those carrying the genotype combinations –18CCSFTPB/413CASFTPC and –18CCSFTPB/436-8CGSFTPC (p = 0.044 and p = 0.03, respectively). The 1580СТSFTPB/ 557ААSFTPC combination was associated with severe RDS regardless of sex (p = 0.019). Among girls, RDS severity was linked to –18CASFTPB/557CCSFTPC and 1580CT/–18CA SFTPB combinations ( p = 0.018 and p = 0.033, respectively), while in boys, the 1580TTSFTPB/413CCSFTPC combination was associated with more severe disease (p = 0.03). In preterm infants with a gestational age of 28–34 weeks, the risk of BPD was associated with the 1580СТSFTPB/413ССSFTPC genotype combination ( p = 0.031). Thus, specific intergenic and intragenic combinations of SFTPB and SFTPC gene polymorphisms are significantly associated with the risk and severity of RDS and BPD in preterm newborns.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CONGENITAL DEFECTS OF THE IMMUNE SYSTEM AS A MANIFESTATION OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN CHILDREN
Background. Currently, monogenic inflammatory bowel disease-like (IBD) pathologies such as congenital immunity defects, genetic epithelial barrier defects and others are becoming increasingly relevant. Objective. To analyze genetic defects associated with IBD-like immunopathology. Material and methods. The study included 46 patients with IBD manifestations aged 18 years or younger, who underwent whole-exome sequencing using the NGS method. All calculations were performed using the R statistical package, version 4.1. Results. There were identified 11 (23,9%) patients with gene mutations indicating congenital defects of the immune system (CDIS). Of these, 3 (27,3%) children were found to have abnormalities in the genes of immune dysregulation - CTLA-4 (c.151C>T (p.Arg 51*)), (FOXP3 (c.851C>T (p.Ala284Val)) and FOXP3 (c.748_750del (p.Lys250del)); 3 (27.3%) patients had abnormalities in the SLC5A1 gene (c.1666-2delA), SLC5A1 gene (c.1666-2delA and c.1680T>G(p.(Cys560Trp)) responsible for the disruption of the barrier function of the epithelium; 2 (18.2%) patients had abnormalities in the PIK3CD gene (c.3061G>A (p.Glu1021Lys)), manifested as CDIS with a predominant deficiency of antibodies; in 2 (18.2%) patients abnormalities in genes affecting cellular and humoral immunity were detected: JAK3 (c.2518C>T(p.Arg840Cys)), CD40LG (c.430G>A (p.Gly144Arg)); and in one case (9,1%) a congenital defect in the number or function of phagocytes – in CFTR gene (c.43delC (p.Leu15fs) and c.1210-11T>G) was established. According to clinical signs, patients with CDIS had only some differences from IBD patients. Conclusion. It is advisable to conduct molecular genetic analysis of target genes in IBD patients with very early onset of gastrointestinal lesions, which allows timely diagnosis of congenital defects of the immune system for subsequent prescription of adequate therapy.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CONGENITAL DEFECTS OF THE IMMUNE SYSTEM AS A MANIFESTATION OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN CHILDREN
Background. Currently, monogenic inflammatory bowel disease-like (IBD) pathologies such as congenital immunity defects, genetic epithelial barrier defects and others are becoming increasingly relevant. Objective. To analyze genetic defects associated with IBD-like immunopathology. Material and methods. The study included 46 patients with IBD manifestations aged 18 years or younger, who underwent whole-exome sequencing using the NGS method. All calculations were performed using the R statistical package, version 4.1. Results. There were identified 11 (23,9%) patients with gene mutations indicating congenital defects of the immune system (CDIS). Of these, 3 (27,3%) children were found to have abnormalities in the genes of immune dysregulation - CTLA-4 (c.151C>T (p.Arg 51*)), (FOXP3 (c.851C>T (p.Ala284Val)) and FOXP3 (c.748_750del (p.Lys250del)); 3 (27.3%) patients had abnormalities in the SLC5A1 gene (c.1666-2delA), SLC5A1 gene (c.1666-2delA and c.1680T>G(p.(Cys560Trp)) responsible for the disruption of the barrier function of the epithelium; 2 (18.2%) patients had abnormalities in the PIK3CD gene (c.3061G>A (p.Glu1021Lys)), manifested as CDIS with a predominant deficiency of antibodies; in 2 (18.2%) patients abnormalities in genes affecting cellular and humoral immunity were detected: JAK3 (c.2518C>T(p.Arg840Cys)), CD40LG (c.430G>A (p.Gly144Arg)); and in one case (9,1%) a congenital defect in the number or function of phagocytes – in CFTR gene (c.43delC (p.Leu15fs) and c.1210-11T>G) was established. According to clinical signs, patients with CDIS had only some differences from IBD patients. Conclusion. It is advisable to conduct molecular genetic analysis of target genes in IBD patients with very early onset of gastrointestinal lesions, which allows timely diagnosis of congenital defects of the immune system for subsequent prescription of adequate therapy.
- Open Access
- 2 December 2023
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Medical series
- Vol. 20 (4) , 278-288
Analysis of the relationship of somatic mutations with the development of leukoplakia and squamous cell carcinoma of the oral mucosa
The molecular genetic basis for pathogenesis of leukoplakia and squamous cell carcinoma of the oral mucosa (OM) is not well understood. Few studies are devoted to this problem and their results are incomplete and contradictory. At the same time, the early diagnosis of OM cancer and the prediction of its development are important public health problems.The aim of the study was to analyze the relationship of somatic mutations with the formation of leukoplakia and squamous cell carcinoma of the oral mucosa.48 altered OM epithelium samples of patients with OM leukoplakia (OML) (24 samples) and OM squamous cell carcinoma (OMSCC) (24 samples) were taken as material for research.The pathogenic and probably pathogenic variants of the TP53, NRAS, and BRAF genes identified in this study, both as one by one and in combination, are associated with high probability (RR 3000‒11 000) with OML with grade 1 epithelial squamous intraepithelial neoplasia. Identified pathogenic and probably pathogenic variants of the ERCC3, HOXB13, KRAS, MSH3, MSH6, PIK3CA, and TP53 genes are associated with a high probability (RR 90‒22 000) with the OMSCC development. The observed pathogenic variants of the KRAS and TP53 genes are highly likely to lead to the formation of OML with grade 1 squamous intraepithelial neoplasia of the epithelium; a subsequent formation of pathogenic variants of the PIC3CA and/or HOXB13 and MSH3 genes leads to malignant transformation of altered OM epithelial cells ( p = 0.0000048). This information allows designing PCR-and NGS-test systems for predicting the development and early diagnosis of OMSCC.
- 2 December 2023
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Medical series
- Vol. 20 (4) , 278-288
Open AccessAnalysis of the relationship of somatic mutations with the development of leukoplakia and squamous cell carcinoma of the oral mucosa
The molecular genetic basis for pathogenesis of leukoplakia and squamous cell carcinoma of the oral mucosa (OM) is not well understood. Few studies are devoted to this problem and their results are incomplete and contradictory. At the same time, the early diagnosis of OM cancer and the prediction of its development are important public health problems.The aim of the study was to analyze the relationship of somatic mutations with the formation of leukoplakia and squamous cell carcinoma of the oral mucosa.48 altered OM epithelium samples of patients with OM leukoplakia (OML) (24 samples) and OM squamous cell carcinoma (OMSCC) (24 samples) were taken as material for research.The pathogenic and probably pathogenic variants of the TP53, NRAS, and BRAF genes identified in this study, both as one by one and in combination, are associated with high probability (RR 3000‒11 000) with OML with grade 1 epithelial squamous intraepithelial neoplasia. Identified pathogenic and probably pathogenic variants of the ERCC3, HOXB13, KRAS, MSH3, MSH6, PIK3CA, and TP53 genes are associated with a high probability (RR 90‒22 000) with the OMSCC development. The observed pathogenic variants of the KRAS and TP53 genes are highly likely to lead to the formation of OML with grade 1 squamous intraepithelial neoplasia of the epithelium; a subsequent formation of pathogenic variants of the PIC3CA and/or HOXB13 and MSH3 genes leads to malignant transformation of altered OM epithelial cells ( p = 0.0000048). This information allows designing PCR-and NGS-test systems for predicting the development and early diagnosis of OMSCC.
- Open Access
- 15 August 2023
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 30 (4) , 37-47
Clinical Significance of Pathogenicity of Somatic Mutations in Oral Leukoplakia: a Prospective Observational Study
Background. The vast majority of malignant neoplasms of the oral mucosa refer to squamous cell carcinomas. The development of squamous cell carcinoma of the oral mucosa is often promoted by previous potentially malignant diseases, with oral leukoplakia dominating among them.Objective. To determine the clinical significance of the pathogenicity of somatic mutations in oral mucosal leukoplakia.Methods. The study material included 24 samples of abnormal epithelium of the oral mucosa from leukoplakia patients. QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) was used for deoxyribonucleic acid (DNA) extraction from the samples. DNA sequencing was performed using IlluminaNextSeq 550 sequencer and TruSight™ Oncology 500 DNA Kit For Use with NextSeq (Illumina, USA). All DNA extractions from biological samples, preparation and sequencing of DNA libraries were performed step-by-step in strict accordance with the guidelines provided with the respective reagent kits. Bioinformatics analysis was carried out using specific software Illumina Base Space (Illumina, USA) and Galaxy Project (The Galaxy Community, a non-profit international project) according to current guidelines. The desired power of the study accounted for 90%. Two Proportions Z test was performed by means of The Sample Size Calculation of Statistica 12 (StatSoft, Inc.) with the set option “one-tailed hypothesis”, because it was initially assumed that pathogenic (oncogenic) genetic variants occur in the tissue of oral leukoplakia much more frequently than in the human reference genome used for sequence alignment.Results. The pathogenic somatic mutations in the TP53, KRAS, APC, NRAs and BRAF genes, identified in this study, alone or in combination, are highly likely (hazard ratio 3000-11000) to be associated with the development of oral mucosal leukoplakia and low-grade epithelial dysplasia. The multiplicity of pathogenic and likely pathogenic genetic variants associated with epithelial dysplasia, as well as the fact that a number of variants do not occur in all patients, suggests that the same histotype of oral mucosal dysplasia may develop under the influence of different mutations.Conclusion. The pathogenic and likely pathogenic variants of the TP53, KRAS, APC, NRAS and BRAF genes, identified in this study, alone or in combination, are highly likely (hazard ratio 3000–11000) to be associated with the development of leukoplakia and low-grade epithelial dysplasia.
- 15 August 2023
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 30 (4) , 37-47
Open AccessClinical Significance of Pathogenicity of Somatic Mutations in Oral Leukoplakia: a Prospective Observational Study
Background. The vast majority of malignant neoplasms of the oral mucosa refer to squamous cell carcinomas. The development of squamous cell carcinoma of the oral mucosa is often promoted by previous potentially malignant diseases, with oral leukoplakia dominating among them.Objective. To determine the clinical significance of the pathogenicity of somatic mutations in oral mucosal leukoplakia.Methods. The study material included 24 samples of abnormal epithelium of the oral mucosa from leukoplakia patients. QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) was used for deoxyribonucleic acid (DNA) extraction from the samples. DNA sequencing was performed using IlluminaNextSeq 550 sequencer and TruSight™ Oncology 500 DNA Kit For Use with NextSeq (Illumina, USA). All DNA extractions from biological samples, preparation and sequencing of DNA libraries were performed step-by-step in strict accordance with the guidelines provided with the respective reagent kits. Bioinformatics analysis was carried out using specific software Illumina Base Space (Illumina, USA) and Galaxy Project (The Galaxy Community, a non-profit international project) according to current guidelines. The desired power of the study accounted for 90%. Two Proportions Z test was performed by means of The Sample Size Calculation of Statistica 12 (StatSoft, Inc.) with the set option “one-tailed hypothesis”, because it was initially assumed that pathogenic (oncogenic) genetic variants occur in the tissue of oral leukoplakia much more frequently than in the human reference genome used for sequence alignment.Results. The pathogenic somatic mutations in the TP53, KRAS, APC, NRAs and BRAF genes, identified in this study, alone or in combination, are highly likely (hazard ratio 3000-11000) to be associated with the development of oral mucosal leukoplakia and low-grade epithelial dysplasia. The multiplicity of pathogenic and likely pathogenic genetic variants associated with epithelial dysplasia, as well as the fact that a number of variants do not occur in all patients, suggests that the same histotype of oral mucosal dysplasia may develop under the influence of different mutations.Conclusion. The pathogenic and likely pathogenic variants of the TP53, KRAS, APC, NRAS and BRAF genes, identified in this study, alone or in combination, are highly likely (hazard ratio 3000–11000) to be associated with the development of leukoplakia and low-grade epithelial dysplasia.
- Open Access
- 27 February 2023
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 30 (2) , 15-24
Germline mutations in patients with oral mucosal leukoplakia and squamous cell carcinoma: a prospective observational study
Background. The number of studies devoted to the molecular genetics of oral mucosal leukoplakia and squamous cell carcinoma is small, while the obtained results are usually preliminary in nature. We can assume the existence of region-specific pathogenic genetic variants involved in the development of oral mucosal leukoplakia and squamous cell carcinoma. With the knowledge of such variants, it would become possible to develop PCR (polymerase chain reaction) and NGS (next-generation sequencing) test systems for the detection of clinically significant germline mutations.Objectives — to identify pathogenic germline genetic variants in patients with oral mucosal leukoplakia accompanied by grade 1 epithelial dysplasia, as well as oral mucosal squamous cell carcinoma, using new-generation sequencing.Methods. Study design: prospective, observational, cross-sectional, without a control group. The sample included patients (48 persons) of either sex (18 years of age or older) with the following proven and morphologically confirmed diagnoses: oral mucosal leukoplakia accompanied by grade 1 squamous intraepithelial neoplasia of epithelium (24 people) and oral mucosal squamous cell carcinoma (24 people), who sought medical care at the Vitebsk Regional Clinical Dental Center and Vitebsk Regional Clinical Oncological Center in 2019–2020. The identified pathogenic and presumably pathogenic genetic variants involved in the development of these diseases were quantitatively assessed. The study was conducted at the Shareable Core Facilities GENOME of the Institute of Genetics and Cytology of the National Academy of Sciences of Belarus. In order to isolate deoxyribonucleic acid (DNA) from blood samples, a QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) was used. The preparation of DNA libraries and sequencing were carried out by means of an Illumina NextSeq 550 sequencing system (Illumina, Inc., USA) using an Illumina Nextera DNA Exome kit (USA). Bioinformatic analysis was conducted using Illumina BaseSpace specialized software (USA) and Galaxy Project (Galaxy Community, an international non-profit project) in accordance with current guidelines. The obtained data were statistically processed employing specialized software packages Statistica 12 (StatSoft, Inc., USA) and MedCalc 18.9.1 (MedCalc Software, Ltd, Belgium).Results. Next-generation whole-exome sequencing of deoxyribonucleic acid samples isolated from the blood of patients with oral mucosal leukoplakia and squamous cell carcinoma has been conducted in the Republic of Belarus for the first time. The total number of unique germline genetic variants in the exome of both groups of patients was shown to be very high, yet most of them were not pathogenic. In the examined patients, the majority of germline mutations were found to be localized only in 19 exome genes: MAP2K3, DNAH5, HSPG2, OBSCN, SYNE1, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-A, HLA-B, PKD1L2, TTN, AHNAK2, PDE4DIP, MUC3A, MUC4, MUC12, MUC16, and MUC17. In both clinical groups, the greatest number of genetic variants (> 40% of the total number) was detected in MUC3A, MUC4, MUC12, and MUC16, responsible for the synthesis of the glycoprotein mucin family.Conclusion. Oral mucosal leukoplakia and squamous cell carcinoma can arise from the pathogenic variants of MUC3A, MUC4, MUC12, and MUC16.
- 27 February 2023
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 30 (2) , 15-24
Open AccessGermline mutations in patients with oral mucosal leukoplakia and squamous cell carcinoma: a prospective observational study
Background. The number of studies devoted to the molecular genetics of oral mucosal leukoplakia and squamous cell carcinoma is small, while the obtained results are usually preliminary in nature. We can assume the existence of region-specific pathogenic genetic variants involved in the development of oral mucosal leukoplakia and squamous cell carcinoma. With the knowledge of such variants, it would become possible to develop PCR (polymerase chain reaction) and NGS (next-generation sequencing) test systems for the detection of clinically significant germline mutations.Objectives — to identify pathogenic germline genetic variants in patients with oral mucosal leukoplakia accompanied by grade 1 epithelial dysplasia, as well as oral mucosal squamous cell carcinoma, using new-generation sequencing.Methods. Study design: prospective, observational, cross-sectional, without a control group. The sample included patients (48 persons) of either sex (18 years of age or older) with the following proven and morphologically confirmed diagnoses: oral mucosal leukoplakia accompanied by grade 1 squamous intraepithelial neoplasia of epithelium (24 people) and oral mucosal squamous cell carcinoma (24 people), who sought medical care at the Vitebsk Regional Clinical Dental Center and Vitebsk Regional Clinical Oncological Center in 2019–2020. The identified pathogenic and presumably pathogenic genetic variants involved in the development of these diseases were quantitatively assessed. The study was conducted at the Shareable Core Facilities GENOME of the Institute of Genetics and Cytology of the National Academy of Sciences of Belarus. In order to isolate deoxyribonucleic acid (DNA) from blood samples, a QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) was used. The preparation of DNA libraries and sequencing were carried out by means of an Illumina NextSeq 550 sequencing system (Illumina, Inc., USA) using an Illumina Nextera DNA Exome kit (USA). Bioinformatic analysis was conducted using Illumina BaseSpace specialized software (USA) and Galaxy Project (Galaxy Community, an international non-profit project) in accordance with current guidelines. The obtained data were statistically processed employing specialized software packages Statistica 12 (StatSoft, Inc., USA) and MedCalc 18.9.1 (MedCalc Software, Ltd, Belgium).Results. Next-generation whole-exome sequencing of deoxyribonucleic acid samples isolated from the blood of patients with oral mucosal leukoplakia and squamous cell carcinoma has been conducted in the Republic of Belarus for the first time. The total number of unique germline genetic variants in the exome of both groups of patients was shown to be very high, yet most of them were not pathogenic. In the examined patients, the majority of germline mutations were found to be localized only in 19 exome genes: MAP2K3, DNAH5, HSPG2, OBSCN, SYNE1, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-A, HLA-B, PKD1L2, TTN, AHNAK2, PDE4DIP, MUC3A, MUC4, MUC12, MUC16, and MUC17. In both clinical groups, the greatest number of genetic variants (> 40% of the total number) was detected in MUC3A, MUC4, MUC12, and MUC16, responsible for the synthesis of the glycoprotein mucin family.Conclusion. Oral mucosal leukoplakia and squamous cell carcinoma can arise from the pathogenic variants of MUC3A, MUC4, MUC12, and MUC16.
- 23 April 2020
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 24 (3) , 9-14
Genetic aspects of congenital anomalies of the kidney and urinary tract
Congenital anomalies of kidney and urinary tract (CAKUT) constitute an average of 25 % of the total number of all genetic anomalies diagnosed in utero and include both individual anomalies of kidney or urinary tract and a combination of such. One of the important problems of pediatric nephrology is the early diagnosis of congenital anomalies of kidney and urinary tract, since untimely detected pathologies lead to a decrease in renal function. The cause of such violations can be genetic factors, environmental factors affecting the woman's body before or during pregnancy. Genetic factor contributes significantly to the formation of CAKUT based on the proven role of mutations in more than 200 genes associated with the development of these anomalies. Since the classical methods of molecular diagnostics do not allow in 90 % of cases to determine occurring mutations, there is a need to apply new genetic testing technologies to identify mutations of genes associated with this group of diseases. Next generation sequencing allows to detect rare genetic variants and concurrently test a large number of genes within a short period of time for the presence of clinically important mutations in them. In addition, the use of next-generation sequencing expands the search for new candidate genes of CAKUT. There are ethnic differences regarding genes involved in the development of congenital anomalies of kidney and urinary tract. The most promising present-day strategy is based on the study of the specific region of patient’s whole exome and the subsequent development of a diagnostic panel.
- 23 April 2020
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 24 (3) , 9-14
Genetic aspects of congenital anomalies of the kidney and urinary tract
Congenital anomalies of kidney and urinary tract (CAKUT) constitute an average of 25 % of the total number of all genetic anomalies diagnosed in utero and include both individual anomalies of kidney or urinary tract and a combination of such. One of the important problems of pediatric nephrology is the early diagnosis of congenital anomalies of kidney and urinary tract, since untimely detected pathologies lead to a decrease in renal function. The cause of such violations can be genetic factors, environmental factors affecting the woman's body before or during pregnancy. Genetic factor contributes significantly to the formation of CAKUT based on the proven role of mutations in more than 200 genes associated with the development of these anomalies. Since the classical methods of molecular diagnostics do not allow in 90 % of cases to determine occurring mutations, there is a need to apply new genetic testing technologies to identify mutations of genes associated with this group of diseases. Next generation sequencing allows to detect rare genetic variants and concurrently test a large number of genes within a short period of time for the presence of clinically important mutations in them. In addition, the use of next-generation sequencing expands the search for new candidate genes of CAKUT. There are ethnic differences regarding genes involved in the development of congenital anomalies of kidney and urinary tract. The most promising present-day strategy is based on the study of the specific region of patient’s whole exome and the subsequent development of a diagnostic panel.